Transcription factors are central players in the regulatory networks that control differentiation in all types of precursor cells and stem cells. Itis well known that transcription factors regulate gene expression, but it is unclear how they regulate differentiation. For instance, in some cases a given transcription factor promotes cell differentiation in one context, and prevents it in another. Melanocytes are an ideal model cell type to explore cellular developmental events because their differentiation is easily scored, they are not essential for life, and loss of melanocyte stem cells in mammals is readily apparent by the consequent hair graying. Moreover, mutations in genes encoding transcription factors and other regulatory molecules cause developmental disorders of pigmentation (e.g., Hirschsprung's disease, Tietz syndrome, Waardenburg syndrome types I- IV, piebaldism). Our long-term objective is to understand the regulatory network governing developmental events in the melanocyte lineage. Here we focus on the transcription factor Activator Protein 2 family (TFAP2A-E). TFAP2A appears to prevent differentiation of melanocyte stem cells, because dominant mutations in TFAP2A cause Branchio Oculo Facial Syndrome (BOFS), which features premature hair graying. By contrast, TFAP2A and its paralog TFAP2E appear to promote differentiation of embryonic melanocytes, as shown by our work in zebrafish. We hypothesize that within melanocyte precursors, TFAP2 proteins function redundantly, and in parallel with microphthalmia-associated transcription factor (MITF), a central regulator of melanocyte biology, to activate genes that effect melanocyte differentiation. To test this model we will conduct knock-down/add-back studies in zebrafish, generate appropriate tissue- specific double mutants in mice, and conduct functional analysis of the promoter of a gene mutually activated by TFAP2 proteins and MITF in cultured in human melanocytes. Next we will examine how TFAP2A functions to maintain melanocyte stem cells (MSC). We hypothesize that in this context, the key function of TFAP2A is to activate KIT. To test this notion we will use zebrafish again for epistasis tests, examine hair graying in a mouse with neural-crest-specific deletion of TFAP2A, and assess functional properties of TFAP2A variants associated with hair graying in BOFS. Finally, we will conduct systematic analyses of potential regulators of TFAP2A expression in melanocytes, and a global analysis of TFAP2A transcriptional targets in melanocytes, which together will position TFAP2A into a regulatory network in melanocytes. Our studies will shed light on novel genetic and molecular networks that underlie normal and pathological development of melanocytes. The new knowledge generated from this work will be of value specifically in the etiology of Waardenburg syndrome and BOFS. More generally, it will illuminate the transcriptional regulation of differentiation in a tractable model cell type.

Public Health Relevance

Disruption of regulatory proteins important in melanocyte development causes disorders of pigmentation including Waardenburg and Branchio Oculo Facial syndromes. Moreover, disruption of melanocyte physiology reduces protection against UV irradiation and elevates the risk for skin cancer. The proposed work will shed light on the genetic regulatory network that underlies the development of melanocyte and melanocyte stem cells. This knowledge will be the basis for more accurate diagnosis of these disorders of pigmentation and prediction of their severity, and will underpin the design of the next generation of therapeutic methods to treat them.

National Institute of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Research Project (R01)
Project #
Application #
Study Section
Arthritis, Connective Tissue and Skin Study Section (ACTS)
Program Officer
Tseng, Hung H
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Iowa
Anatomy/Cell Biology
Schools of Medicine
Iowa City
United States
Zip Code
Seberg, Hannah E; Van Otterloo, Eric; Cornell, Robert A (2017) Beyond MITF: Multiple transcription factors directly regulate the cellular phenotype in melanocytes and melanoma. Pigment Cell Melanoma Res 30:454-466
Seberg, Hannah E; Van Otterloo, Eric; Loftus, Stacie K et al. (2017) TFAP2 paralogs regulate melanocyte differentiation in parallel with MITF. PLoS Genet 13:e1006636
Laurette, Patrick; Strub, Thomas; Koludrovic, Dana et al. (2015) Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cells. Elife 4:
Kubic, Jennifer D; Lui, Jason W; Little, Elizabeth C et al. (2015) PAX3 and FOXD3 Promote CXCR4 Expression in Melanoma. J Biol Chem 290:21901-14
Kubic, J D; Little, E C; Lui, J W et al. (2015) PAX3 and ETS1 synergistically activate MET expression in melanoma cells. Oncogene 34:4964-74
Azaiez, Hela; Decker, Amanda R; Booth, Kevin T et al. (2015) HOMER2, a stereociliary scaffolding protein, is essential for normal hearing in humans and mice. PLoS Genet 11:e1005137
Rambow, Florian; Job, Bastien; Petit, Valérie et al. (2015) New Functional Signatures for Understanding Melanoma Biology from Tumor Cell Lineage-Specific Analysis. Cell Rep 13:840-853
Hallberg, Andrea R; Vorrink, Sabine U; Hudachek, Danielle R et al. (2014) Aberrant CpG methylation of the TFAP2A gene constitutes a mechanism for loss of TFAP2A expression in human metastatic melanoma. Epigenetics 9:1641-7
Praetorius, Christian; Grill, Christine; Stacey, Simon N et al. (2013) A polymorphism in IRF4 affects human pigmentation through a tyrosinase-dependent MITF/TFAP2A pathway. Cell 155:1022-33